Teodori, E.; Braconi, L.; Bua, S.; Lapucci, A.; Bartolucci, G.; Manetti, D.; Romanelli, M.N.; Dei, S.; Supuran, C.T.; Coronnello, M.
Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer Cells. Molecules 2020, 25, 1748.
https://doi.org/10.3390/molecules25071748
AMA Style
Teodori E, Braconi L, Bua S, Lapucci A, Bartolucci G, Manetti D, Romanelli MN, Dei S, Supuran CT, Coronnello M.
Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer Cells. Molecules. 2020; 25(7):1748.
https://doi.org/10.3390/molecules25071748
Chicago/Turabian Style
Teodori, Elisabetta, Laura Braconi, Silvia Bua, Andrea Lapucci, Gianluca Bartolucci, Dina Manetti, Maria Novella Romanelli, Silvia Dei, Claudiu T. Supuran, and Marcella Coronnello.
2020. "Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer Cells" Molecules 25, no. 7: 1748.
https://doi.org/10.3390/molecules25071748
APA Style
Teodori, E., Braconi, L., Bua, S., Lapucci, A., Bartolucci, G., Manetti, D., Romanelli, M. N., Dei, S., Supuran, C. T., & Coronnello, M.
(2020). Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer Cells. Molecules, 25(7), 1748.
https://doi.org/10.3390/molecules25071748